Document:

EX-10.1

 Exhibit 10.1 

CATALYST BIOSCIENCES, INC. 

CONSULTING AGREEMENT 
 This
Consulting Agreement (this “Agreement”) is entered into as of 13 October 2021 to be effective upon the date of termination of your employment (the “Effective Date”) between Catalyst Biosciences, Inc., a
Delaware corporation (“Company”), and Clinton Musil (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant
to Company and perform such activities under the terms of this Agreement. 
 NOW, THEREFORE, Consultant and Company agree as follows: 

1.    SERVICES AND COMPENSATION 

(a)    Consultant agrees to act as a consultant to Company with respect to such matters and projects as are mutually
agreed from time to time by and between Consultant and Company, and to perform the services described on Exhibit A hereto (collectively, the “Services”). 

(b)    Company agrees to pay Consultant the compensation set forth in Exhibit A hereto for the
performance of the Services. 
 2.    CONFIDENTIALITY 

(a)    “Confidential Information” means any proprietary information, technical data, trade secrets or know-how, including, but not limited to, research and product plans, products, services, markets, developments, inventions, processes, formulas, technology, marketing, finances or other business information
disclosed to Consultant by Company either directly or indirectly in writing, orally or otherwise. Confidential Information also includes all Inventions (as defined below) and any other information or materials generated in connection with the
Services. 
 (b)    Consultant shall not, during or subsequent to the term of this Agreement, use any Confidential
Information for any purpose whatsoever other than the performance of the Services on behalf of Company, or disclose Confidential Information to any third party. Consultant agrees that Confidential Information shall remain the sole property of
Company. Consultant further agrees to take all reasonable precautions to prevent any unauthorized disclosure or use of Confidential Information. Notwithstanding the above, Consultant’s obligation under this Section 2(b) relating to
Confidential Information shall not apply to information which (i) is known to Consultant at the time of disclosure to Consultant by Company as evidenced by written records of Consultant, (ii) has become publicly known and made generally
available through no wrongful act of Consultant, or (iii) has been rightfully received by Consultant from a third party authorized to make such disclosure. 

(c)    Consultant agrees that Consultant will not, during the term of this Agreement, improperly use or disclose to
Company any proprietary information or trade secrets of any former or current employer or other person or entity to which Consultant has a duty to keep in confidence such information and that Consultant will not bring onto the premises of Company
any unpublished document or proprietary information belonging to such employer, person or entity unless consented to in writing by the same. Consultant will indemnify Company and hold it harmless from and against all claims, liabilities, damages and
expenses, including reasonable attorneys’ fees and costs of suit, arising out of or in connection with any violation or claimed violation by Company of such third party’s rights resulting in whole or in part from Company’s use of the
work product of Consultant under this Agreement. 

 (d)    Consultant recognizes that Company has received and in the future
will receive from third parties their confidential or proprietary information subject to a duty on Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that
Consultant owes Company and such third parties, during the term of this Agreement and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation
or to use it except as necessary in carrying out the Services for Company consistent with Company’s agreement with such third party. 

(e)    Upon the termination of this Agreement, or upon Company’s earlier request, Consultant will deliver to Company
all Confidential Information and Company’s property relating thereto and all tangible embodiments thereof, in Consultant’s possession or control. 

(f)    DTSA Notice. Consultant acknowledges receipt of the following notice pursuant to 18 U.S.C. § 1833(b)(1)
(Defend Trade Secrets Act): 
 An individual shall not be held criminally or civilly liable under any federal or state trade secret law for
the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law. An individual shall not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who
files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any
document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. 

3.    OWNERSHIP 

(a)    Consultant hereby irrevocably assigns to Company all right, title and interest in and to any information
(including, without limitation, business plans and/or business information), technology, know-how, materials, notes, records, designs, ideas, inventions, improvements, devices, developments, discoveries,
compositions, trade secrets, processes, methods and/or techniques, whether or not patentable or copyrightable, that are conceived, reduced to practice or made by Consultant alone or jointly with others in the course of performing the Services or
through the use of Confidential Information (collectively, “Inventions”). 
 (b)    Consultant agrees
to sign, execute and acknowledge or cause to be signed, executed and acknowledged without cost, but at the expense of Company, any and all documents and to perform such acts as may be necessary, useful or convenient for the purposes of perfecting
the foregoing assignments and obtaining, enforcing and defending intellectual property rights in any and all countries with respect to Inventions. It is understood and agreed that Company or Company’s designee shall have the sole right, but not
the obligation, to prepare, file, prosecute and maintain patent applications and patents worldwide with respect to Inventions. 

  
 -2- 

 (c)    Upon the termination of this Agreement, or upon Company’s
earlier requests, Consultant will deliver to Company all property relating to, and all tangible embodiments of, Inventions in Consultant’s possession or control. 

(d)    Consultant agrees that if, in the course of performing the Services, Consultant incorporates into any Invention
developed hereunder any invention, improvement, development concept, discovery or other proprietary subject matter owned by Consultant or in which Consultant has an interest (“Item”), Consultant will inform Company in writing
thereof, and Company is hereby granted and shall have a non-exclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made, modify, reproduce, display, use and sell such Item as part of
or in connection with the exploitation of such Invention. 
 (e)    Consultant agrees that if Company is unable because
of Consultant’s unavailability, mental or physical incapacity, or for any other reason, to secure Consultant’s signature to apply for or to pursue any application or registration for any intellectual property rights covering any Invention,
then Consultant hereby irrevocably designates and appoints Company and its duly authorized officers and agents as Consultant’s agent and attorney-in-fact, to act
for and in Consultant’s behalf to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of such intellectual property rights thereon with the same legal force and effect as if
executed by Consultant. 
 4.    REPORTS. Consultant agrees, from time to time during the term of this Agreement,
to keep Company advised as to Consultant’s progress in performing the Services and, as reasonably requested by Company, prepare written reports with respect thereto. It is understood that the time required in the preparation of such written
reports shall be considered time devoted to the performance of the Services by Consultant. All such reports prepared by Consultant shall be the sole property of Company. 

5.    TERM AND TERMINATION 

(a)    This Agreement will commence on the Effective Date and will continue until the earlier of 31 December 2021, or
termination as provided below. 
 (b)    Either party may terminate this Agreement upon prior written notice thereof to
the other party. 
 (c)    Either party may terminate this Agreement upon material breach by the other party provided
that the non-breaching party shall provide written notice of such breach and an opportunity to cure such breach (if curable) for a period of thirty (30) days. 

(d)    Upon termination of this Agreement, all rights and duties of the parties hereunder shall cease except: 

(i)    Company shall be obliged to pay, within thirty (30) days after receipt of Consultant’s final statement,
all amounts owing to Consultant for unpaid Services completed by Consultant and related expenses, if any, in accordance with the provisions of Section 1 hereof, and 

(ii)    Sections 2, 3, 5(d), 6, 7 and 9 shall survive termination of this Agreement. 

6.    INDEPENDENT CONTRACTOR. Nothing in this Agreement shall in any way be construed to constitute Consultant as an
agent, employee or representative of Company, but Consultant shall perform the Services as an independent contractor. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant
pursuant to this Agreement. 

  
 -3- 

 7.    ARBITRATION AND EQUITABLE RELIEF. Company and Consultant
agree that any dispute or controversy arising out of, in relation to, or in connection with this Agreement, or the making, interpretation, construction, performance or breach hereof, shall be finally settled by binding arbitration in San Francisco,
California under the then current rules of the American Arbitration Association by one (1) arbitrator appointed in accordance with such rules. The arbitrator may grant injunctive or other relief in such dispute or controversy. The decision of
the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court of competent jurisdiction. The parties agree that, any provision of applicable law
notwithstanding, they will not request, and the arbitrator shall have no authority to award, punitive or exemplary damages against either party. The costs of the arbitration, including administrative and arbitrator’s fees, shall be shared
equally by the parties. Each party shall bear the cost of its own attorneys’ fees and expert witness fees. 

  
 -4- 

 8.    CONFLICTING OBLIGATIONS. Consultant hereby certifies that he
or she has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Consultant from complying with the provisions hereof, and further certifies that Consultant will not enter
into any such conflicting agreement during the term of this Agreement. Subject to written waivers that may be provided by the Company upon request, which shall not be unreasonably withheld, Consultant agrees that, during the term of this Agreement,
Consultant will not directly or indirectly (i) provide any services in the Field of Interest to any other business or commercial entity, (ii) provide any services for any company that is competitive with the Company and shall list in
Exhibit B hereto any other companies for whom Consultant is providing services (“Outside Companies”), or (iii) participate in the formation of any business or commercial entity in the Field of Interest or otherwise
competitive with the Company. The “Field of Interest” means the research, development, manufacturing or commercialization of human Factor VIIa or Factor IX products, or varients thereof, or of complement-related products or product
candidates that would compete with products or product candidates that the Company has in development as of the date of the Effective Date. Without limiting the foregoing, Consultant agrees to use his or her best efforts (A) to segregate
Consultant’s Services performed under this Agreement from Consultant’s work done for the Outside Companies so as to minimize any questions of disclosure of, or rights under, any inventions, (B) to notify the CEO of the Company if at
any time the Consultant believes that such questions may result from his or her performance under this Agreement and (C) to assist the Company in fairly resolving any questions in this regard which may arise. The Services performed hereunder
will not be conducted on time that is required to be devoted to any other third party. The Consultant shall not use the funding, resources and facilities of any other third party, without the prior written consent of the Company, to perform Services
hereunder and shall not perform the Services hereunder in any manner that would give any third party rights or access to the product of such Services. 

9.    GENERAL. This Agreement (together with the Exhibits hereto) is the sole agreement and understanding between
Company and Consultant concerning the subject matter hereof, and it supersedes all prior agreements and understandings with respect to such matter. Any required notice shall be given in writing by customary means with receipt confirmed at the
address of each party set forth below, or to such other address as either party may substitute by written notice to the other. Consultant shall not subcontract any portion of Consultant’s duties under this Agreement without the prior written
consent of Company. Neither this Agreement nor any right hereunder or interest herein may be assigned or transferred by Consultant without the express written consent of Company. Company may assign this Agreement to any entity that succeeds to
substantially all of the business or assets of Company. This Agreement shall be governed by the laws of the State of California, without reference to its conflicts of law principles. This Agreement may only be amended or modified by a writing signed
by both parties. Waiver of any term or provision of this Agreement or forbearance to enforce any term or provision by either party shall not constitute a waiver as to any subsequent breach or failure of the same term or provision or a waiver of any
other term or provision of this Agreement. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect
without said provision, provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to either Company or Consultant. 

  
 -5- 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective
Date. 
  

									
	CATALYST BIOSCIENCES, INC.	 		 	
					
	By:	 	/s/ Nassim Usman, Ph.D.	 		 		 	/s/ Clinton Musil
					
	Print Name:	 	Nassim Usman, Ph.D.	 		 		 	Clinton Musil
					
	Title:	 	President & CEO	 		 		 	

 CATALYST BIOSCIENCES, INC. 

CONSULTING AGREEMENTExhibit 10.1

 

Employment
Agreement

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”),
made and entered into as of October 13, 2021 (the “Effective Date”), is by and between Lordstown Motors Corp.,
a Delaware corporation (“Company”), and Adam Kroll (“Executive”). Certain capitalized terms shall
have the meaning given to them in Section 7 below.

 

WHEREAS, Company and Executive desire to enter
into an employment agreement on the terms and conditions set forth herein;

 

WHEREAS, Company considers Executive a “key
executive” and agrees to provide Executive the significant consideration described in this Agreement as and for Company’s
retention of Executive; and

 

WHEREAS, Company and Executive desire to enter
into this Agreement as of the Effective Date and this Agreement shall supersede all prior employment terms and conditions, whether or
not in writing.

 

NOW, THEREFORE, in consideration of the premises
and of the covenants and agreements hereinafter contained, and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto do hereby covenant and agree as follows:

 

1.             Employment
Period. Subject to the terms and conditions of this Agreement, Company hereby agrees to employ Executive as the date hereof and as
the Chief Financial Officer (“CFO”) of Company during the Employment Period, and Executive hereby agrees to be employed
by Company and provide services for and on behalf of Company during the Employment Period subject to and in accordance with this Agreement.
The period from October 25, 2021 until the Termination Date shall be referred to as the “Employment Period.”

 

2.             Duties.
Executive agrees that, during the Employment Period, Executive will serve Company diligently and in good faith and will, subject to the
exceptions below, devote his full business time, energies and talents to serving as the CFO of Company, subject to and at the direction
of the Company’s Chief Executive Officer (the “CEO”). Executive shall: (a) have such duties and responsibilities
commensurate with his position as CFO and as may be reasonably assigned to Executive from time to time by the CEO; (b) perform
all lawful duties assigned to Executive in good faith, subject to the reasonable direction of the CEO; and (c) act in accordance
with written Company policies as may be in effect from time to time. Notwithstanding the foregoing, during the Employment Period, Executive
may devote reasonable time to activities other than those required under this Agreement, including activities of a charitable, educational,
religious or similar nature (including professional associations); provided such activities do not inhibit, prohibit, interfere
with or breach any of Executive’s duties under this Agreement or common law, or otherwise conflict in any material way with the
Company Business.

 

3.             Compensation
and Benefits. Subject to the terms and conditions of this Agreement, Company shall pay Executive, and Executive agrees to accept from
Company, as compensation in full for his services to be performed hereunder and for the faithful performance and observance of all of
his obligations to Company hereunder, the following annual salary and other compensation during the Employment Period:

 

     

     

    

 

(a)              Base
Salary. Company shall pay to Executive a base salary in the amount of $450,000 per annum (the “Annual Base Salary”),
payable in equal periodic installments less all customary payroll deductions (with such annual salary for any part of a month to be paid
on a pro- rated basis), in accordance with customary policies and normal payroll practices of Company.

 

(b)              Annual
Bonus. Executive shall be eligible to receive an annual bonus during the Employment Period with an annual target bonus equal to 80%
of Annual Base Salary, based on Company and individual performance and subject to the discretion of the Company’s board of directors
(the “Board of Directors”) or a committee thereof. For the fiscal year ending December 31, 2021, Executive will
be entitled to receive an annual bonus that is equal to no less than Executive’s annual target bonus, prorated based upon the number
of days from October 25, 2021 through December 31, 2021, which shall be paid on or before January 15, 2022 subject to
Executive’s continued employment through the payment date.

 

(c)              Benefits.
From the Effective Date and during the Employment Period, Executive and Executive’s dependents, as the case may be, shall be eligible
to participate in all executive plans and programs as in effect from time to time thereof generally available to other executives of
Company and subject to the terms and conditions thereof, including a 401(k) Plan, medical and dental, and disability benefits. Notwithstanding
the foregoing, Company shall be permitted to amend, add to or eliminate the benefit plans at any time and at Company’s sole discretion.

 

(d)             Vacation.
Executive shall be entitled to vacation time consistent with Company’s established programs and policies as may be in effect during
the Employment Period; provided that Executive shall be entitled to four weeks of vacation per year (which, if not used in a fiscal
year, will not be carried to the next fiscal year).

 

(e)              Expense
Reimbursement. Executive shall be reimbursed by Company, on terms and conditions that are substantially similar to those that apply
to other similarly situated executives of Company, for reasonable out-of-pocket expenses for entertainment, travel, meals, lodging and
similar items which are actually incurred by Executive in connection with the Company Business. Executive’s position with Company
will be based at Company’s Michigan facility. From the Effective Date and during the Employment Period, Company shall reimburse
Executive for reasonable travel expenses, including to Company’s California, Michigan and Ohio facilities. Notwithstanding anything
to the contrary in this Section 3(e), Company shall be required to reimburse Executive for the expenses described in this Section 3(e) only
to the extent that Executive complies with the policies, practices and procedures of Company for incurring expenses and submitting expense
reports, receipts, or similar documentation of any such expenses.

 

    	 	2	 

     

    

 

(f)               Equity
Awards. In connection with the commencement of Executive’s employment with the Company, on the Effective Date, Executive will
be granted an award of (i) 200,000 stock options with an exercise price equal to $5.12 per share and (ii) 250,000 restricted
stock units pursuant to the 2020 Incentive Plan, subject to the terms and conditions set forth in award agreements between Company and
Executive (such awards, the “Initial Equity Awards”). The Initial Equity Awards will vest ratably on each of the first,
second and third anniversary of the grant date, subject to Executive’s continued employment with the Company through each such
vesting date. Company intends to make annual equity compensation awards and Executive will be eligible for annual equity awards based
on Executive’s seniority. It is expected that Executive will receive equity awards in each of 2022 and 2023 that are equivalent
in value to the Initial Equity Awards and that Company will grant these awards during the first six months of 2022 and 2023, respectively,
subject to Executive’s and Company’s performance. All stock options granted by Company to Executive shall permit Executive
to exercise vested options for up to six months following termination of employment for any reason other than Cause (but in no event
later than the full option term).

 

(g)              Indemnification;
D&O coverage. At all times, during the Employment Period, (i) Executive shall be eligible for indemnification (including
the advancement of attorneys’ fees) pursuant to the Company’s bylaws to the fullest extent of the law, and (ii) Executive
shall be covered by Company’s directors’ and officers’ insurance policy (the “D&O Insurance Policy”)
with Side A and Side B limits not less than in effect on the Effective Date, if available on commercially reasonable terms.

 

4.             Term
and Termination.

 

(a)              Term.
The term of Executive’s employment hereunder shall commence on the Effective Date and continue until terminated. The effective
date of any termination hereunder shall be referred to as the “Termination Date”.

 

(b)              Termination.
Executive’s employment hereunder may be terminated on the following terms and conditions:

 

(i)               by
Company for Cause, effective upon written notice from Company to Executive, following the expiration, without cure, of any applicable
cure period;

 

(ii)              by
Company for any reason other than for Cause, effective 30 days following written notice from Company to Executive, provided that
Company may place Executive on paid leave during any portion of such 30 day period;

 

(iii)             by
Executive for any reason, effective 30 days following written notice from Executive to Company or any earlier date as may be determined
by Company in its sole discretion, provided that Company may place Executive on paid leave during any portion of such period;
or

 

(iv)             by
Change of Control as defined herein.

 

(c)              Death/Disability.
This Agreement and Executive’s employment hereunder shall terminate immediately and automatically by reason of Executive’s
death or Disability and Executive (or his estate) shall receive all vested equity awards and pro rata vesting of unvested equity awards
(based on the number of full or partial months served from the most recent vesting event to the date Executive’s Termination Date).
In the event Executive’s employment with Company terminates, for any reason whatsoever, including death or Disability, Executive
shall be entitled to the benefits described in Section 4(h).

 

    	 	3	 

     

    

 

(d)              Severance
Payment.

 

(i)               In
the event of a Termination Upon Change of Control, or if Company terminates Executive’s employment other than for Cause or Executive
resigns for Good Reason, Executive shall be entitled to receive an amount equal to the sum of eight months of Executive’s Annual
Base Salary and $25,000, which shall be paid according to the following schedule (subject to Section 4(d)(iv)): (a) a
lump sum payment equal to one-half of such amount shall be payable within ten days of following the Termination Date, and (b) one-fourth
of the balance of such amount shall be payable within ten days of each of the three-month, six-month, nine-month and 12 month anniversaries
of the Termination Date (and in each case no interest shall accrue on such amount); provided, however, that if Section 409A
of the Internal Revenue Code of 1986, as amended (the “Code”) would otherwise apply to such cash severance payment,
it instead shall be paid at such time as permitted by Section 409A of the Code. In addition to the foregoing severance payment, in
the event of Executive’s termination for any reason other than (i) Cause or (ii) Executive’s resignation without
Good Reason, Executive shall be entitled to receive, within ten days following the termination, a lump sum payment equal to 100% of (a) any
actual bonus amount earned with respect to a previous year to the extent that all the conditions for payment of such bonus have been satisfied
(excluding any requirement to be in employment with Company as of a given date which is after the Termination Date) and any such bonus
was earned but is unpaid on the Termination Date; and (b) the target bonus then in effect for Executive for the year in which
such termination occurs, such payment to be prorated to reflect the full number of months Executive remained in the employ of Company;
provided, however, that if Section 409A of the Code would otherwise apply to such cash payment, it instead shall be paid at such
time as permitted by Section 409A of the Code. To illustrate, if Executive’s target bonus at 100% equals $120,000 for the calendar
year and Executive is terminated on October 15th, then the foregoing payment shall equal $100,000 (i.e., ten (10) months’
prorated bonus at one hundred percent (100%) with October counting as a full month worked).

 

(ii)              [RESERVED]

 

(iii)             Notwithstanding
anything in this Agreement to the contrary, payments to be made upon a termination of employment under this Agreement will be made upon
a “separation from service” within the meaning of Section 409A of the Code. Each payment under this Agreement shall
be treated as a separate payment for purposes of Section 409A of the Code. To the maximum extent permissible payments under this
Agreement shall be treated as exempt from Section 409A first pursuant to the exception for short-term deferrals, then pursuant to
the exception for payments related to separations from service, and then for de minimis amounts

 

(iv)             Executive
shall forfeit all rights to payment of severance pursuant to this Section 4(d) or otherwise unless he signs and delivers
a general release and separation agreement, in form and substance reasonably acceptable to Company within 60 days after Executive’s
termination of employment. Notwithstanding anything to the contrary contained herein, no severance payment will be due and payable until
Executive executes and delivers such general release and separation agreement and it is not subject to revocation, if applicable.

 

    	 	4	 

     

    

 

(e)              Equity
Compensation Acceleration. If Company terminates Executive’s employment other than for Cause or Executive resigns for Good
Reason, then subject to Section 4(d)(iv), the vesting and exercisability of all then outstanding stock options (or any other
equity award, including, without limitation, stock appreciation rights and restricted stock units) granted to Executive under any equity
incentive plan (the “Company Plans”) adopted by the Board of Directors shall be accelerated as to 100% of the shares
subject to any such equity awards granted to Executive. Upon any vesting of restricted stock units, the Company shall withhold from the
shares delivered to Executive a sufficient number of shares to allow the Company to remit on Executive’s behalf state and federal
taxes calculated at the highest marginal tax rate.

 

(f)               [RESERVED]

 

(g)              Indemnification.
In connection with Executive’s termination from Company, regardless of the reason, (a) Company shall continue to indemnify
Executive against all claims related to actions arising prior to the termination of Executive’s employment to the fullest extent
permitted by law (including without limitation advancement of attorneys’ fees), and (b) Company or its successor shall continue
to provide coverage under a D&O Insurance Policy for not less than 36 months following such termination on substantially the same
terms of the D&O Insurance Policy in effect immediately prior to such termination.

 

(h)              Termination
from all Positions; Rights and Payments Upon Termination. In connection with Executive’s termination from Company, regardless
of the reason, (1) Executive agrees that, effective as of the Termination Date, Executive shall resign and be terminated from all
positions Executive holds as a director, officer or employee of Company or any Subsidiary or Affiliate thereof and shall execute any
necessary documentation to properly effectuate such termination and (2) Executive shall be entitled to the Minimum Payments, in
addition to any payments or benefits to which Executive may be entitled under the express terms of any executive benefit plan or as required
by law. Any payments to be made to Executive pursuant to this Section 4 shall be made in accordance with Company’s
customary policies and normal payroll practices.

 

5.             Restrictive
Covenants.

 

(a)              Confidential
Information. Executive recognizes and acknowledges that he may receive certain confidential and proprietary information and trade
secrets of Company, its Affiliates and Subsidiaries, including (i) internal business information (including, information relating
to strategic plans and practices, business, accounting, financial or marketing plans, practices or programs, training practices and programs,
salaries, bonuses, incentive plans and other compensation and benefits information and accounting and business methods); (ii) identities
of, individual requirements of, specific contractual arrangements with, and information about, Company, its Affiliates and Subsidiaries
and their respective confidential information; (iii) industry research compiled by, or on behalf of Company and its Affiliates
and Subsidiaries, including, without limitation, identities of potential target companies, management teams, and transaction sources
identified by, or on behalf of, Company and its Affiliates and Subsidiaries; (iv) compilations of data and analyses, processes,
methods, track and performance records, data and data bases relating thereto; and (v) computer software documentation, data
and data bases and updates of any of the foregoing; (collectively, “Confidential Information”). Executive will
not, during or after the term of this Agreement, whether through an Affiliate or otherwise, take commercial or proprietary advantage
of or profit from any Confidential Information or disclose Confidential Information to any Person for any reason or purpose whatsoever,
except (i) to authorized representatives and employees of Company or its Affiliates and Subsidiaries and as otherwise may be proper
in the course of performing Executive’s obligations under this Agreement or (ii) as is required to be disclosed by order of
a court of competent jurisdiction, administrative body or governmental body, or by subpoena, summons or legal process, or by law, rule or
regulation; provided that, unless otherwise prohibited by law, rule or regulation, Executive shall provide to the Board of
Directors prompt notice of any such disclosure. For purposes of this Section 5(a), Confidential Information does not include
any information that is or becomes generally known to the other participants in the industry in which Company and its Subsidiaries operate
other than as a result of any breach of nondisclosure by any Person. The limitations in this Section 5(a) are in addition
to, and not in lieu of, any other restrictions that Executive may be bound by (whether by contract or otherwise), including Company’s
Proprietary Information and Inventions Agreement.

 

    	 	5	 

     

    

 

Notwithstanding anything to the contrary in this
Agreement or otherwise, nothing shall limit Executive’s rights under applicable law to provide truthful information to any governmental
entity or to file a charge with or participate in an investigation conducted by any governmental entity. Notwithstanding the foregoing,
Executive agrees to waive Executive’s right to recover monetary damages in connection with any charge, complaint or lawsuit filed
by Executive or anyone else on Executive’s behalf (whether involving a governmental entity or not); provided that Executive
is not agreeing to waive, and this Agreement shall not be read as requiring Executive to waive, any right Executive may have to receive
an award for information provided to any governmental entity. Executive is hereby notified that the immunity provisions in Section 1833
of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state
trade secret law for any disclosure of a trade secret that is made (1) in confidence to federal, state or local government officials,
either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of
the law, (2) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (3) to Executive’s
attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in
the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is
not disclosed except pursuant to court order.

 

(b)              Documents
and Property. All records, files, documents and other materials or copies thereof relating to the Company Business, which Executive
shall prepare, receive, or use shall be and remain the sole property of Company, shall not be used by Executive in any manner that would
be adverse to Company’s interests, and, other than in connection with the performance by Executive of his duties hereunder, shall
not be removed from the premises of Company or any Subsidiary without Company’s prior written consent, and shall be promptly returned
to Company upon Executive’s termination of employment hereunder for any reason whatsoever, together with all copies (including
copies or recordings in electronic form), abstracts, notes or reproductions of any kind made from or about the records, files, documents
or other materials.

 

    	 	6	 

     

    

 

(c)              Non-Competition/Non-Solicitation.
From the Effective Date and during the Employment Period and for a two (2) year period thereafter (the “Restricted Period”),
Executive will not, directly or indirectly, individually or as a shareholder, director, manager, member, officer, employee, agent, consultant
or advisor of any Person: (i) acquire or hold any economic or financial interest in, act as a partner, member, shareholder, consultant,
employee or representative of, render services to, or otherwise operate, engage in or hold an interest in any Person that engages in,
or engages in the management or operation of any Person that engages in any business that competes with the Company Business; (ii) solicit
orders from or seek or propose to do business with any customer or supplier of the business relating to the Company Business; or
(iii) influence or attempt to influence any customer, supplier, employee, contractor, representative or advisor of the Company Business
to curtail, terminate or refrain from maintaining its, his or her relationship with Company or any of its Subsidiaries; provided, however,
that the ownership of less than 1% of the voting stock of any publicly held corporation shall not be a violation of this Agreement.

 

(d)              Non-Disparagement.
During and after Executive’s employment with Company, neither Company nor Executive will make any adverse or derogatory statements,
remarks or comments, oral or written, directly or indirectly, to any individual or entity about or with reference to or with respect to
Executive or Company, or any of its executives, officers, managers, members, directors or agents. The foregoing shall not be violated
by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings
(including, without limitation, depositions in connection with such proceedings).

 

(e)              Remedies
for Breach of Covenants. Executive acknowledges and expressly agrees that the covenants contained in this Section 5 are
reasonable with respect to their duration, geographical area and scope. Executive further acknowledges that, in light of his position
with Company and access to Confidential Information from the Effective Date and during the Employment Period, the restrictions contained
in this Section 5 are reasonable and necessary for the protection of the legitimate business interests of Company, that they
create no undue hardships, that any violation of these restrictions would cause substantial injury to Company and such interests, and
that such restrictions were a material inducement to Company to enter into this Agreement. In the event of any violation or threatened
violation of these restrictions, Company, in addition to and not in limitation of, any other rights, remedies or damages available to
Company under this Agreement or otherwise at law or in equity, shall be entitled to preliminary and permanent injunctive relief, to prevent
or restrain any such violation by Executive and any and all Persons directly or indirectly acting for or with him, as the case may be.

 

6.             Inventions
and Innovations. Executive acknowledges and agrees that he is separately bound by the Proprietary Information and Invention Agreement
with Company. In addition, and notwithstanding anything to the contrary in the Proprietary Information and Invention Agreement, Executive
acknowledges and agrees that all right, title and interest in and to any past, present and future inventions, business applications,
know-how, customer lists, trade secrets, innovations, methods, designs, ideas, improvements, copyrights, patents, domain names, trademarks,
trade dress and other intellectual property which Executive personally develops or creates in whole or in part at any time and at any
place during his employment with Company, and which is, directly or indirectly, related to or usable in connection with, the business
activities of Company (all items set forth above are hereafter collectively referred to as the “Inventions and Innovations”),
shall be and remain forever the sole and exclusive property of Company, and Executive thus automatically assigns and agrees to assign
any such right, title and interest in his possession, or that he acquires, to Company. In this regard, Executive acknowledges and agrees
that any Inventions and Innovations embodying copyrightable subject matter are “works made for hire,” and Executive automatically
assigns and agrees to assign all right, title and interest to Company in the same if such Inventions and Innovations are not “works
made for hire.” Executive agrees to promptly reveal all information relating to the Inventions and Innovations to Company and cooperate
with Company to execute such documents as may be necessary to establish ownership and protection in Company’s name for the Inventions
and Innovations. Notwithstanding the foregoing, Inventions and Innovations shall not include any publicly available information
or any information that was developed by Executive on his own time with his own tools and/or materials and without the resources of Company
or any Subsidiary thereof.

 

    	 	7	 

     

    

 

7.             Definitions.
As used throughout this Agreement, all of the terms defined in this Section 7 shall have the meanings given below.

 

“2020 Incentive Plan” shall mean
the Company’s 2020 Equity Incentive Plan.

 

“Affiliate” shall mean each individual,
company, corporation, partnership, limited liability company, joint venture or other business entity, which is, directly or indirectly,
controlled by, controls, or is under common control with, Company, where “control” means (i) the ownership of a majority
of the voting securities or other voting interests or other equity interests of any company, corporation, partnership, limited liability
company, joint venture or other business entity, or (ii) the possession, directly or indirectly, of the power to direct or cause
the direction of the management and policies of such company, corporation, partnership, limited liability company, joint venture or other
business entity.

 

“Agreement” shall have the meaning
set forth in the preamble.

 

“Annual Base Salary” shall have
the meaning set forth in Section 3(a).

 

“Board of Directors” shall have
the meaning set forth in Section 3(b ).

 

“Cause” shall mean the Board of
Directors’ determination in good faith that Executive has:

 

(i)               disregarded
or refused to substantially perform his duties and obligations to Company as required by this Agreement and the Board of Directors (other
than any such failure resulting from his Disability or Executive’s termination of his employment with Company for any reason);

 

(ii)              breached
a fiduciary responsibility to Company in any material respect;

 

(iii)             commission
of an act of fraud, embezzlement or other misappropriation of funds;

 

    	 	8	 

     

    

 

(iv)             breached
any confidentiality or proprietary information agreement in any material respect between Executive and Company;

 

(v)              acted
with gross negligence or willful misconduct when undertaking Executive’s duties;

 

(vi)             breached
this Agreement;

 

(vii)            Executive’s
excessive and unreasonable absences from Executive’s duties for any reason (other than authorized leave or leave required by law
or as a result of Executive’s Disability); or

 

(viii)           Executive’s
indictment for, conviction of, or plea of guilty or nolo contendere to, (A) a felony, (B) a misdemeanor (other
than traffic or motor vehicle violations), or (C) any other act, omission or event that, in any such case, has caused or
is likely to cause economic harm to Company or any of its Subsidiaries or the image, reputation and/or goodwill of Company or its Subsidiaries
or that Company in good faith believes is reasonably likely to cause material harm to the image, reputation and/or goodwill of Company
or its Subsidiaries, their respective products, services and/or trade/service marks;

 

Notwithstanding the foregoing, prior to Company’s
termination of Executive for Cause above, Company shall give Executive written notice specifying in reasonable detail the existence of
any condition and Executive shall have 30 days from the date of Executive’s receipt of such notice in which to cure the condition
giving rise to Cause (if curable).

 

“CEO” shall have the meaning set
forth in Section 1.

 

“CFO” shall have the meaning set
forth in Section 1.

 

“Change of Control” means:

 

(i)               one
Person (or more than one Person acting as a group) acquires ownership of stock of Company that, together with the stock held by such
person or group, constitutes more than 35% of the total fair market value or total voting power of the stock of Company; provided,
that, a Change in Control shall not occur if any Person (or more than one Person acting as a group) owns more than 50% of the total fair
market value or total voting power of Company’s stock and acquires additional stock;

 

(ii)              a
majority of the members of the Board of Directors are replaced during any 12-month period by directors whose appointment or election
is not endorsed by a majority of the Board of Directors before the date of appointment or election; or

 

(iii)             one
Person (or more than one person acting as a group), acquires (or has acquired during the 12-month period ending on the date of the most
recent acquisition) assets from Company that have a total gross fair market value equal to or more than 50% of the total gross fair market
value of all of the assets of Company immediately before such acquisition(s).

 

    	 	9	 

     

    

 

A
transaction shall not constitute a Change in Control if: (a) its sole purpose is to change the state of Company’s incorporation;
or (b) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons
who held Company’s securities immediately before such transaction.

 

“Code” shall have the meaning
set forth in Section 4(d).

 

“Company” shall have the meaning
set forth in the preamble.

 

“Company Business” shall mean
the business of developing, designing and manufacturing battery-electric vehicles under 10,001 GVW.

 

“Confidential Information” shall
have the meaning set forth in Section 5(a).

 

“D&O Insurance Policy” shall
have the meaning set forth in Section 3(g).

 

“Disability” shall mean that Executive
is unable to effectively perform the essential functions of his job by reason of any medically determinable physical or mental impairment
that can be expected to result in death or can be expected to last for not less than 90 consecutive days or 125 non-consecutive days,
in either case during any 12-month period (unless a longer period is required under applicable law, then during such longer period), and
in any case as determined in good faith by an independent doctor selected in good faith by the Board of Directors and mutually acceptable
to Executive.

 

“Effective Date” shall have the
meaning set forth in the preamble.

 

“Executive” shall have the meaning
set forth in the preamble.

 

“Employment Period” shall have
the meaning set forth in Section 1.

 

“Good Reason” is defined as the
occurrence of any of the following: (i) a breach of this Agreement by Company (including without limitation any of the indemnification
provisions); (ii) a material reduction in Executive’s Base Salary or Annual Bonus, (iii) a material change in the
geographic location where Executive must perform services; or (iv) Executive has a material reduction in position, status, duties
or responsibilities, or is assigned duties materially inconsistent with his position (including without limitation if Executive ceases
to be the CFO of a public company which is the ultimate parent of the Company). If Executive wishes to terminate his employment for Good
Reason, he shall first give Company 30 days prior written notice of the circumstances constituting Good Reason and an opportunity to cure,
and such notice must be given to Company within 30 days of Executive becoming aware of such circumstances.

 

“Initial Equity Awards” shall
have the meaning set forth in Section 3(f).

 

“Inventions and Innovations” shall
have the meaning set forth in Section 6.

 

    	 	10	 

     

    

 

“Minimum Payments” shall mean,
as applicable, the following amounts:

 

(i)               Executive’s
earned but unpaid Annual Base Salary for the period ending on the Termination Date, with such payments to be made in accordance with Section 3(a);

 

(ii)              Executive’s
accrued but unpaid vacation days for the period ending on the Termination Date; and

 

(iii)             Executive’s
unreimbursed business expenses and all other items earned and owed to Executive through and including, the Termination Date.

 

“Person” shall mean any individual,
sole proprietorship, partnership, joint venture, trust, unincorporated association, corporation, limited liability company, entity or
governmental entity (whether federal, state, county, city or otherwise and including any instrumentality, division, agency or department
thereof).

 

“Restricted Period” shall have
the meaning set forth in Section 5(c).

 

“Subsidiary” shall mean, with
respect to any Person, any corporation, partnership, limited liability company, association or business entity of which: (i) if a
corporation, a majority of the total voting power of shares of stock entitled (irrespective of whether, at the time, stock of any other
class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) to vote in the
election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one
or more of the other Subsidiaries of that Person or a combination thereof; or (ii) if a partnership, limited liability company,
association or other business entity, either (A) a majority of partnership or other similar ownership interests thereof is at the
time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof or
(B) that Person is a general partner, managing member, manager or managing director of such partnership, limited liability company,
or other business entity. For purposes hereof and unless otherwise indicated, the term “Subsidiary” refers to a Subsidiary
of Company.

 

“Termination Date” shall mean
the date of termination of Executive’s employment as determined in accordance with Section 3.

 

“Termination Upon Change of Control”
means:

 

(i)               any
termination of the employment of Executive by Company without Cause during the period commencing on or after the date that Company enters
into a definitive agreement that results in a Change of Control (even though still subject to approval by Company’s stockholders
and other conditions and contingencies, but provided that the Change of Control actually occurs) and ending on the date which is 12 months
following the Change of Control; or

 

(ii)              any
resignation by Executive for Good Reason where (i) such Good Reason occurs during the period commencing on or after the date that
Company enters into a definitive agreement that results in a Change of Control (even though still subject to approval by Company’s
stockholders and other conditions and contingencies, but provided that the Change of Control actually occurs) and ending on the date which
is 12 months following the Change of Control, and (ii) such resignation occurs at or after such Change of Control and in any event
within six months following the occurrence of such Good Reason.

 

    	 	11	 

     

    

 

(iii)             Notwithstanding
the foregoing, the term “Termination Upon Change of Control” shall not include any termination of the employment of Executive:
(1) by Company for Cause; (2) by Company as a result of the Disability of Executive; (3) as a result of the
death of Executive; or (4) as a result of the voluntary termination of employment by Executive for any reason other than Good
Reason.

 

8.             Notices.
Notices and all other communications under this Agreement shall be in writing and shall be deemed given if (i) delivered personally,
(ii) delivered by a recognized overnight courier service, or (iii) mailed by United States registered or certified mail, return
receipt requested, postage prepaid, addressed as follows:

 

If to Company to: 

 

Lordstown Motors Corp. 

2300 Hallock Young Road, S.W. 

Lordstown, OH 44481 

Attention: General Counsel 

 

If to Executive, to:

 

The address on file with the Company’s Human Resources department
or to such other address as either party may furnish to the other in writing, except that notices of changes of address shall be effective
only upon receipt.

 

9.             Applicable
Law. All questions concerning the construction, validity and interpretation of this Agreement and the performance of the obligations
imposed by this Agreement shall be governed by the internal laws of the State of Ohio applicable to agreements made and wholly to be
performed in such state without regard to conflicts of law provisions of any jurisdiction.

 

10.           FORUM
SELECTION. ALL ACTIONS OR PROCEEDINGS IN ANY WAY, MANNER OR RESPECT, ARISING OUT OF OR FROM OR RELATED TO THIS AGREEMENT SHALL BE
LITIGATED IN COURTS HAVING SITUS WITHIN TRUMBULL COUNTY, OHIO EXECUTIVE HEREBY CONSENTS AND SUBMITS TO THE JURISDICTION OF THE STATE
AND FEDERAL COURTS LOCATED WITHIN TRUMBULL COUNTY, OHIO. EXECUTIVE HEREBY WAIVES ANY RIGHT IT MAY HAVE TO TRANSFER OR CHANGE THE
VENUE OF ANY LITIGATION BROUGHT AGAINST EXECUTIVE BY COMPANY IN ACCORDANCE WITH THIS SECTION.

 

11.           WAIVER
OF JURY TRIAL. EXECUTIVE AND COMPANY HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION
IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS OR EVENTS CONTEMPLATED HEREBY OR ANY COURSE OF
CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY HERETO. THE PARTIES HERETO EACH AGREE THAT
ANY AND ALL SUCH CLAIMS AND CAUSES OF ACTION TRIED BY A COURT SHALL BE TRIED WITHOUT A JURY. EACH OF THE PARTIES HERETO FURTHER WAIVES
ANY RIGHT TO SEEK TO CONSOLIDATE ANY SUCH LEGAL PROCEEDING IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER LEGAL PROCEEDING IN WHICH
A JURY TRIAL CANNOT OR HAS NOT BEEN WAIVED.

 

    	 	12	 

     

    

 

12.           Entire
Agreement; Severability. This Agreement, together with the Proprietary Information and Inventions Agreement and the Company Plans,
constitute the entire agreement between Executive and Company concerning the subject matter hereof, and supersedes all prior negotiations,
undertakings, agreements and arrangements with respect thereto, whether written or oral. If a court of competent jurisdiction determines
that any provision of this Agreement is invalid or unenforceable, then the invalidity or unenforceability of that provision shall not
affect the validity or enforceability of any other provision of this Agreement and all other provisions shall remain in full force and
effect. The various covenants and provisions of this Agreement are intended to be severable and to constitute independent and distinct
binding obligations. Without limiting the generality of the foregoing, if the scope of any covenant contained in this Agreement is too
broad to permit enforcement to its full extent, such covenant shall be enforced to the maximum extent permitted by law, and Executive
hereby agrees that such scope may be judicially modified accordingly.

 

13.           Withholding
of Taxes. Company may withhold from any amounts or other benefits payable under this Agreement all federal, state, city or other taxes
as may be required pursuant to any law, governmental regulation or ruling.

 

14.           No
Assignment. Executive’s rights to receive payments or benefits under this Agreement shall not be assignable or transferable
whether by pledge, creation of a security interest or otherwise, other than a transfer by will, by the laws of descent or distribution
or to a revocable living trust of Executive. In the event of any attempted assignment or transfer contrary to this Section 14,
Company shall have no liability to pay any amount so attempted to be assigned or transferred. This Agreement shall inure to the benefit
of and be enforceable by Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees.

 

15.           Successors.
This Agreement shall be binding upon and inure to the benefit of Company, its successors and assigns (including any company into or with
which Company may merge or consolidate).

 

16.           Survival.
The provisions of Sections 4, 5, 6, 7, 9, 10, 11, 12, 13, and 14
shall survive the termination of this Agreement.

 

17.           Amendment;
Waivers. This Agreement may not be amended or modified except by written agreement signed by Executive and Company. No waiver of
any provision or condition of this Agreement by any party shall be valid unless set forth in a writing signed by such party. No such
waiver shall be deemed to be a waiver of any other or similar provision or condition, or of any future event, act, breach or default,
and no course of dealing shall be implied or arise from any waiver or series of waivers (written or otherwise) of any right or remedy
hereunder.

 

    	 	13	 

     

    

 

18.           Joint
Participation. The parties hereto participated jointly in the negotiation and preparation of this Agreement, and each party has had
the opportunity to obtain the advice of legal counsel and to review and comment upon the Agreement. Accordingly, it is agreed that no
rule of construction shall apply against any party or in favor of any party. This Agreement shall be construed as if the parties
jointly prepared this Agreement, and any uncertainty or ambiguity shall not be interpreted against one party and in favor of the other.

 

19.           No
Conflicting Agreement. Executive hereby represents and warrants to Company that he is not subject to any existing non- competition
or other restrictive agreements, clauses or arrangements, written or oral, that in any way prohibit or constrain in any material respect
his acceptance of and/or performance of duties pursuant to this Agreement, or that in any manner circumscribe the scope of activities
or other business that he is entitled to pursue and consummate on behalf of Company.

 

20.           Construction;
Miscellaneous. Whenever used in this Agreement, the singular shall include the plural and vice versa (where applicable), the use
of the masculine, feminine or neuter gender shall be deemed to include the other genders (unless the context otherwise requires), the
words “hereof,” “herein,” “hereto,” “hereby,” “hereunder,” and other words
of similar import refer to this Agreement as a whole (including exhibits), the words “include,” “includes” and
 “including” means “include, without limitation,” “includes, without limitation” and “including,
without limitation,” respectively. The headings used in this Agreement are for convenience only, shall not be deemed to constitute
a part hereof, and shall not be deemed to limit, characterize or in any way affect the construction or enforcement of the provisions
of this Agreement. This Agreement may be executed in any number of identical counterparts, any of which may contain the signatures of
less than all parties, and all of which together shall constitute a single agreement. All remedies of any party hereunder are cumulative
and not alternative, and are in addition to any other remedies available at law, in equity or otherwise.

 

[Signature page follows.]

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF, the parties have executed this
Agreement as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	LORDSTOWN MOTORS CORP.

 

	 	By:	/s/
         Daniel Ninivaggi
	 	Name:	Daniel
    Ninivaggi
	 	Its:	Chief Executive Officer

 

		EXECUTIVE:

 

	 	/s/
         Adam Kroll
	 	Adam Kroll

 

[Signature Page to Employment Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]